Global CDMO OXB Acquires FDA-Approved Site in Research Triangle
Post-pandemic, international biopharmaceutical companies are seeking reliable U.S. supply chains and streamlined production processes, relying on contract development and manufacturing organizations (CDMOs).
North Carolina, with its long-time leadership in the clinical research organizations (CRO) industry, is a logical place for expansion or building facilities, requiring specialized equipment, government-regulated facilities, and a highly educated workforce.
Industry leaders, such as FUJIFILM Biotechnologies and Genentech, have recently broken ground on large manufacturing facilities in Holly Springs.
Now, North Carolina newcomer OXB, a UK-based CDMO in cell and gene therapy, announced on Oct. 7 that it has acquired the former Resilience site on Alexander Drive.
The 125,000-square-foot facility is approved by the U.S. Food and Drug Administration for commercial-scale viral vector manufacturing.
Author's summary: OXB acquires FDA-approved site in North Carolina.
More News
- Amanda Nunes’ UFC Return Date Announced
- [Kayla Harrison shoots down Ronda Rousey comparison's ahead of her fight with Amanda Nunes]
- The Number Of Jaguar Recalls For 2025 (So Far) May Surprise You
- The Good Quote (@thegoodquote) - Inspirational Community
- Kayla - Two warriors. One outcome. Who you got??
- Kayla Harrison shares her true feelings about being co-main at UFC 324
- It goes, boys! and Other Great Climbing Quotes
- Edson Barboza Fight Week Interview | UFC 323
- Kayla Harrison's manager: There's a lot of beef with Ronda Rousey
- lookup noun - Definition, usage